First Manhattan’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

First Manhattan’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-260,553	Closed	-$3.03M	–	1718
2022 Q1	$3.03M	Sell	260,553 -327,282	-56%	-$3.9M	0.01%	310
2021 Q4	$10.7M	Buy	587,835 +143,346	+32%	+$1.82M	0.04%	164
2021 Q3	$5.27M	Buy	444,489 +73,200	+20%	+$1.07M	0.02%	216
2021 Q2	$6.38M	Hold	371,289	–	–	0.02%	202
2021 Q1	$6.79M	Buy	371,289 +191,765	+107%	+$4.02M	0.03%	196
2020 Q4	$3.38M	Buy	179,524 +69,800	+64%	+$1.51M	0.02%	259
2020 Q3	$2.32M	Buy	109,724 +11,547	+12%	+$270K	0.01%	281
2020 Q2	$2.83M	Buy	98,177 +3,414	+4%	+$103K	0.02%	271
2020 Q1	$3.32M	Buy	+94,763	New	+$3.07M	0.02%	247

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

First Manhattan's OYST Position: Q2 2022 in Review

First Manhattan sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 260,553 shares — an estimated $3.03M sold.

First Manhattan first reported a position in OYST in Q1 2020 and held it in 9 quarters. The position peaked at $10.7M in Q4 2021. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

First Manhattan reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
First Manhattan sold 260,553 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $3.03M.
First Manhattan first reported a position in Oyster Point Pharma, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
First Manhattan's Oyster Point Pharma, Inc. Common Stock position peaked at $10.7M in Q4 2021.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on First Manhattan's 13F filing for Q2 2022, filed 15 Aug 2022.